Mapping Microclimate PH Distribution Inside Protein-encapsulated PLGA Microspheres Using Confocal Laser Scanning Microscopy
Overview
Authors
Affiliations
The pH in the aqueous pores of poly(lactide-co-glycolide) (PLGA) matrix, also referred to as microclimate pH (μpH), is often uncontrolled, ranging from highly acidic to neutral pH range. The μpH distribution inside protein-encapsulated PLGA microspheres was quantitatively evaluated using confocal laser scanning microscopy. The fluorescent response of Lysosensor yellow/blue dextran used to map μpH in PLGA was influenced by the presence of encapsulated protein. The nonprotonated form of pyridyl group on the fluorescence probe at neutral pH was responsible for the interference, which was dependent on the type and concentration of protein. A method for correction of this interference based on estimating protein concentration inside the microspheres was established and validated. After correction of the influence, the μpH distribution kinetics inside microspheres was evaluated for different PLGA 50/50 microsphere formulations under physiological conditions for 4 weeks. Generally, the μpH acidity increased with the progression of incubation time. The coincorporation of poorly soluble base, magnesium carbonate, in the microspheres prolonged the appearance of detectable acidity for up to 3 weeks. Co-addition of an acetate buffer was able to control the μpH over a slightly acidic range (around pH 4.7) after two week incubation. Microspheres prepared from a lower polymer concentration exhibited a higher μpH, likely owing to reduced diffusional resistance to acidic degradation products. The stability of protein was enhanced by addition of MgCO(3), acetate buffer, or by reduced polymer concentration in the preparation, as evidenced by more soluble protein recovered after incubation. Hence, the μpH imaging technique developed can be employed in the future for optimization of formulation strategies for controlling μpH and stabilizing encapsulated proteins.
Patient-Centric Long-Acting Injectable and Implantable Platforms─An Industrial Perspective.
Alidori S, Subramanian R, Holm R Mol Pharm. 2024; 21(9):4238-4258.
PMID: 39160132 PMC: 11372838. DOI: 10.1021/acs.molpharmaceut.4c00665.
Peptide Acylation in Aliphatic Polyesters: a Review of Mechanisms and Inhibition Strategies.
Sheikhi M, Nemayandeh N, Shirangi M Pharm Res. 2024; 41(4):765-778.
PMID: 38504074 DOI: 10.1007/s11095-024-03682-6.
Basic Salt Additives Modulate the Acidic Microenvironment Around In Situ Forming Implants.
Hopkins K, Wakelin E, Romick N, Kennedy J, Simmons E, Solorio L Ann Biomed Eng. 2022; 51(5):966-976.
PMID: 36454398 DOI: 10.1007/s10439-022-03109-6.
Beugeling M, Amssoms K, Cox F, De Clerck B, Van Gulck E, Verwoerd J Pharmaceutics. 2019; 11(10).
PMID: 31623333 PMC: 6835792. DOI: 10.3390/pharmaceutics11100510.
Liu J, Xu Y, Wang Y, Ren H, Meng Z, Liu K Pharm Res. 2019; 36(8):119.
PMID: 31165279 DOI: 10.1007/s11095-019-2640-5.